
COVID-19 vaccine gave 100 per cent protection against severe/critical illness to study volunteers, research shows
Results from a COVID-19 vaccine trial – to which MFT consented the first global participant – are ‘extremely positive’.
Read moreResults from a COVID-19 vaccine trial – to which MFT consented the first global participant – are ‘extremely positive’.
Read moreSaint Mary's researchers have revealed new ways of calculating older mums’ personal risk of serious pregnancy problems like having stillborn, premature, or very small babies.
Read moreResearch led by Professor Bill Newman, Consultant at MFT, could revolutionise the diagnosis and treatment for people with Perrault syndrome.
Read moreChildren with adrenal insufficiency have a higher risk of dying than those with other lifelong conditions, according to research by The University of Manchester and MFT scientists.
Read morePioneering care and research across Manchester University Hospitals NHS Foundation Trust (MFT) features in a new national exhibition on cancer breakthroughs.
Read moreImplantable heart technology is being used in Manchester to assess when a patient is at high risk of dying, thanks to Manchester University NHS Foundation Trust-led research.
Read moreManchester University NHS Foundation Trust (MFT) has appointed new leadership of its Diagnostics and Technology Accelerator (DiTA).
Read moreNew global research has found pressures from the COVID-19 pandemic can still take a physical toll on mums-to-be, even if they don’t catch the virus.
Read more